Mumbai, Nov 14 (IANS) On November 12, 2024, IIT Bombay hosted a symposium titled “Pioneering the Future of Healthcare and Diagnostics Using 4D Omics”.
The event was organized by the Proteomics Lab, Department of Biosciences and Bioengineering (BSBE) which showcased groundbreaking advancements in 4D-proteomics and 4D omics, areas primed to revolutionize diagnostics and personalized healthcare.
The event was graced by Bollywood actress Mahima Chaudhry, who attended as a special guest and shared her deeply personal connection to the symposium’s focus on cancer diagnostics.
As a breast cancer survivor, Chaudhry expressed her pride in joining the symposium to raise awareness of this cutting-edge technology that has potential to enhance early diagnosis and improve treatment outcomes for cancer patients. “Cancer is a subject incredibly close to my heart,” Chaudhry stated, “And I am honored to be here to witness the launch of such an impactful technology.”
Professor Sanjeeva Srivastava, the convener of the event and an esteemed expert in proteomics, highlighted the importance of 4D omics technology in healthcare and diagnostics, particularly for cancers and chronic diseases. “4D omics adds a crucial temporal dimension to biomolecular research,” explained Prof. Srivastava. “By integrating genomics, proteomics, transcriptomics, and metabolomics with time-sensitive analysis, researchers can gain unprecedented insights into the progression of diseases and the effectiveness of therapies.
This symposium and the launch of the timsTOF 4D-proteomics setup, the first of its kind in India, are significant steps towards improving healthcare outcomes.” Dr. Balram Bhargava, former Director General of the Indian Council of Medical Research (ICMR), and Dr. Judith Steen from Harvard Medical School, were among the esteemed speakers at the symposium.
Dr. Bhargava emphasized the vast potential of 4D omics technology, highlighting its ability to revolutionize healthcare. He noted that integrating multidimensional omics data would lead to more precise and personalized medicine, significantly impacting cancer diagnostics and maternal and child healthcare.
The symposium spotlighted the transformative potential of 4D omics technology in advancing maternal and child health, alongside its applications in cancer diagnostics
–IANS
ayk/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
